6533b859fe1ef96bd12b83b7

RESEARCH PRODUCT

Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.

Thomas LemsterBrigitte BaldeyrouBrigitte BaldeyrouAmélie LansiauxAmélie LansiauxMarie-paule HildebrandMarie-paule HildebrandUlf PindurChristoph KeuserKerstin BenzschawelMarie-hélène David-cordonnier

subject

Stereochemistrymedicine.drug_classTopoisomerase InhibitorsDNA FootprintingContext (language use)Antineoplastic AgentsLigandschemistry.chemical_compoundStructure-Activity RelationshipCell Line TumorDrug DiscoverymedicineStructure–activity relationshipHumansPyrrolesPharmacologybiologyMolecular StructureChemistryTopoisomeraseOrganic ChemistryDistamycinsNetropsinGeneral MedicineDNADNA Minor Groove BindingIntercalating AgentsAcridoneDrug DesignAcridinebiology.proteinTopoisomerase inhibitorDNA

description

In the context of the design and synthesis of minor groove binding and intercalating DNA ligands some new oligopyrrole carboxamides were synthesized. These hybrid molecules (combilexins) possess a variable and conformatively flexible spacer at the N-terminal end. As intercalating tricyclic systems acridone, acridine, anthraquinones and in a special case iminostilbene terminate the N-terminal end of the pyrrole chain. The cytotoxicity was examined by the NCI antitumor screening, furthermore, biophysical as well as biochemical studies were performed in order to get some information about the DNA binding properties and topoisomerase inhibition effect of this new series of molecules.

10.1016/j.ejmech.2006.12.039https://pubmed.ncbi.nlm.nih.gov/17433851